BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA, Medical Device Industry Pros to Discuss Quality at Regulatory Affairs Professionals Society Forum in Irvine, CA


10/25/2012 9:30:25 AM

Rockville, MD, USA—Medical device company executives and US Food and Drug Administration (FDA) officials will gather at the Beckman Center in Irvine, CA, 1 November, for The RAPS/FDA Case for Quality Forum—Los Angeles, presented by the Regulatory Affairs Professionals Society (RAPS). The forum will provide an opportunity for FDA and industry representatives to discuss how to improve the quality of medical devices to advance public health.

The interactive forum will enable members of the medical device community to share their thoughts on best practices, what works and what tends to inhibit quality efforts while hearing directly from FDA about the agency’s Case for Quality initiative, including timelines for short- and long-term goals, mechanisms for stakeholder involvement and plans for how this initiative will be implemented at the national and regional levels.

Scheduled speakers include:

• Alonza Cruse, director, Los Angeles District, FDA (invited)

• Ann Ferriter, director, Division of Risk Management Operations, Office of Compliance, CDRH, FDA

• Donna Godward, vice president, quality, regulatory, compliance, Johnson & Johnson

• Cecilia Kimberlin, vice president, quality and regulatory, Abbott

• William MacFarland, director, Division of Enforcement B, Office of Compliance, CDRH, FDA

• Jan Welch, deputy director for regulatory affairs, Office of Compliance, CDRH, FDA

Members of the working media who wish to cover The Case for Quality Forum should contact Zachary Brousseau, senior manager, communications for RAPS at zbrousseau@raps.org or +1 301 770 2920, ext. 245.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Europe and Asia, and chapters and affiliates worldwide. RAPS.org



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES